Cited by 187Botulinum Toxin and Related Neurological DisordersFacial Rejuvenation and Surgery TechniquesVenomous Animal Envenomation and Studies

A synthetic hexapeptide (Argireline) with antiwrinkle activity

Open access
Blanes‐Mira, C., Clemente, J., Jodas, G., Gil, A., Fernández‐Ballester, G., Ponsati, B., Gutierrez, L., Pérez‐Payá, E. +1 more·2002·International Journal of Cosmetic Science

Abstract

Synopsis: Botulinum neurotoxins (BoNTs) represent a revolution in cosmetic science because of their remarkable and long‐lasting antiwrinkle activity. However, their high neurotoxicity seriously limits their use. Thus, there is a need to design and validate non‐toxic molecules that mimic the action of BoNTs. The hexapeptide Ac‐EEMQRR‐NH 2 (coined Argireline) was identified as a result of a rational design programme. Noteworthy, skin topography analysis of an oil/water (O/W) emulsion containing 10% of the hexapeptide on healthy women volunteers reduced wrinkle depth up to 30% upon 30 days treatment. Analysis of the mechanism of action showed that Argireline significantly inhibited neurotransmitter release with a potency similar to that of BoNT A, although as expected, it displayed much lower efficacy than the neurotoxin. Inhibition of neurotransmitter release was due to the interference of the hexapeptide with the formation and/or stability of the protein complex that is required to drive Ca 2+ ‐dependent exocytosis, namely the vesicular fusion (known as SNARE) complex. Notably, this peptide did not exhibit in vivo oral toxicity nor primary irritation at high doses. Taken together, these findings demonstrate that Argireline is a non‐toxic, antiwrinkle peptide that emulates the action of currently used BoNTs. Therefore, this hexapetide represents a biosafe alternative to BoNTs in cosmetics.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1467-2494.2002.00153.x

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a split-face controlled study of ten healthy subjects with little photodamaged skin, 10% Argireline significantly reduced rhytide depth after 30 days compared with vehicle lotion.

    “The authors found that compared to the control, 10% Argireline can significantly reduce rhytide depth after 30 days of treatment (Level IIb Evidence).”

    From Cosmeceuticals in photoaging: A review. (2024) · cites this paper as [45]

    The ‘Antiwrinkle test on healthy humans’ section describes ten healthy women applying 10% Argireline to one side of the face and the base emulsion to the other for 30 days. ‘Argireline attenuates wrinkle depth in vivo in healthy volunteers’ reports significantly reduced wrinkle depth with Argireline and no significant topographic change with the base emulsion. Our copy does not describe the volunteers as having little photodamaged skin. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Stegman, S.J., Tromovitch, T.A. and Glogau, R.G.The skin of the aging face in cosmetic dermatologic surgery, 2nd edn. Mosby year book, St. Louis. MO, pp. 5^15 (1990).

Cited by

Sorted by citations

Authors
Blanes‐Mira, C., Clemente, J., Jodas, G., Gil, A., Fernández‐Ballester, G., Ponsati, B., Gutierrez, L., Pérez‐Payá, E., & Ferrer‐Montiel, A.
Affiliations
  • Universitat de Miguel Hernández d'Elx (ES)
  • Lipotec (Spain) (ES)
  • Universitat de València (ES)
Venue
International Journal of Cosmetic Science
Publisher
Wiley
Published
2002-10
Volume
24
Issue
5
Pages
303-310
ISSN
  • 0142-5463 (ISSN-L)
  • 1468-2494
OpenAlex
W2144640136
Cited by
187
References
13
Citations by year
2026: 16 · 2025: 12 · 2024: 11 · 2023: 14 · 2022: 11 · 2021: 13 · 2020: 12 · 2019: 8 · 2018: 7 · 2017: 7 · 2016: 7 · 2015: 10 · 2014: 4 · 2013: 11 · 2012: 7
FWCI
1.11
Type
journal article
Language
en
Open access
Locations
  • International Journal of Cosmetic Science (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Neurology › Botulinum Toxin and Related Neurological Disorders
  • Health Sciences › Medicine › Dermatology › Facial Rejuvenation and Surgery Techniques
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Venomous Animal Envenomation and Studies
Keywords
hexapeptide, botulinum toxin, neurotransmitter release inhibition, SNARE complex, wrinkle depth, skin topography, cosmetic safety, rational peptide design

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review